Health technology investors have taken a more selective approach1 in the healthcare space in 2023. For the medical device community, we cannot view those circumstances as a challenge, but rather, an opportunity to affect meaningful change through innovation. They will be asked to produce a thoroughly vetted roadmap that accounts for the instability of the market and the supply chain issues5 that have roiled medical device makers. With the proper approach, device makers can adapt to the demands of today’s economy and will continue to impact patient care with their innovations. Sean Gilligan is the chief operating officer at AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease.

Source: Forbes September 11, 2023 17:48 UTC